Publications by authors named "Guohe Lin"

Claim this Profile
D
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis.
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, Chen Fu

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Polystyrene Microplastics and Copper Ion Co-Contamination on the Growth of Rice Seedlings.
Huiyu Jin, Guohe Lin, Mingzi Ma, Lin Wang, Lixiang Liu

Nanomaterials (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies.
Bo-Hua Kuang, Wen-Xuan Zhang, Guo-He Lin, Chen Fu, Ru-Bo Cao

Front Endocrinol (Lausanne)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies.
Ru-Bo Cao, Yao Ge, Wen-Xuan Zhang, Guo-He Lin, Bo-Hua Kuang

Medicine (Baltimore)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies.
Bi-Cheng Wang, Guo-He Lin, Bo-Hua Kuang, Ru-Bo Cao

Front Endocrinol (Lausanne)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World Studies.
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin

Target Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer: a survival analysis of reconstructed patient-level data.
Bi-Cheng Wang, Chen Fu, Guo-He Lin

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel-fosfamide monotherapy or in combination with doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcoma: A pooled analysis of randomized clinical trials.
Xin-Xiu Liu, Yan-Hong Han, Bo-Hua Kuang, Guo-He Lin, Bi-Cheng Wang

Medicine (Baltimore)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer.
Shao-Xian Cheng, Qiu-Chi Chen, Guo-He Lin, Yan-Hong Han, Bi-Cheng Wang

Medicine (Baltimore)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poziotinib in non-small-cell lung cancer patients with HER2 exon 20 mutations: A pooled analysis of randomized clinical trials.
Bi-Cheng Wang, Bo-Hua Kuang, Xin-Xiu Liu, Guo-He Lin

Medicine (Baltimore)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer.
Xin-Xiu Liu, Guo-He Lin, Bi-Cheng Wang

Medicine (Baltimore)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials.
Bi-Cheng Wang, Wen-Xuan Zhang, Bo-Hua Kuang, Guo-He Lin

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: A comparative analysis of retrospective studies versus prospective studies.
Bi-Cheng Wang, Bo-Ya Xiao, Bo-Hua Kuang, Guo-He Lin

Dermatol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Alone or in Combination with Stereotactic Body Radiotherapy in Advanced Lung Cancer: A Pooled Analysis of Randomized Clinical Trials.
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin

J Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UHRF1 Induces Metastasis in Thyroid Cancer.
Bo-Hua Kuang, Guo-He Lin, Quentin Liu, Bi-Cheng Wang

J Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis.
Bi-Cheng Wang, Bo-Hua Kuang, Xin-Xiu Liu, Guo-He Lin, Quentin Liu

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.
Zhan-Jie Zhang, Liang-Liang Shi, Xiao-Hua Hong, Bo-Ya Xiao, Guo-He Lin

PLoS One· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pooled analysis of adding olanzapine to guideline-recommended antiemetic therapy for breast cancer patients treated with an anthracycline and cyclophosphamide in prospective and retrospective studies.
Bo-Ya Xiao, Tong Su, Yu-Jia Huang, Guo-He Lin, Zhao-Bo Liu

Support Care Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies.
Bi-Cheng Wang, Bo-Ya Xiao, Guo-He Lin

BMC Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials.
Bi-Cheng Wang, Bo-Hua Kuang, Bo-Ya Xiao, Guo-He Lin

Front Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tolerability and safety analysis of adding granulocyte-macrophage colony-stimulating factor to local radiotherapy in a case series of seven patients with thoracic cancer.
Bi-Cheng Wang, Peng-Cheng Li, Bo-Hua Kuang, Zhan-Jie Zhang, Bo-Ya Xiao, Guo-He Lin

Ann Palliat Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6 versus 12 months of adjuvant trastuzumab in HER2+ early breast cancer: A systematic review and meta-analysis.
Bi-Cheng Wang, Bo-Ya Xiao, Ji-Quan Fan, Guo-He Lin, Chang Wang

Medicine (Baltimore)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis".
Bi-Cheng Wang, Bo-Ya Xiao, Peng-Cheng Li, Bo-Hua Kuang, Wang-Bing Chen, Guo-He Lin

J Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Apatinib Treatment for Patients with Advanced Intrahepatic Cholangiocarcinoma.
Guohe Lin, Bicheng Wang, Xiuwei Wu, Tong Sun, Lili Chen

Cancer Manag Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.
Bi-Cheng Wang, Bo-Ya Xiao, Peng-Cheng Li, Bo-Hua Kuang, Wang-Bing Chen, Guo-He Lin

J Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis